Cargando…
Chemodenervation of the Larynx
Botulinum neurotoxin (BoNT) has existed for thousands of years; however, it was not medically utilized until investigations into its therapeutic use began in sincerity during the late 1970s and 1980s. This, coupled with the reclassification of spasmodic dysphonia as a focal dystonia, led to the use...
Autores principales: | Kaye, Rachel, Blitzer, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705971/ https://www.ncbi.nlm.nih.gov/pubmed/29099066 http://dx.doi.org/10.3390/toxins9110356 |
Ejemplares similares
-
Ultrasound Guidance for Botulinum Neurotoxin Chemodenervation Procedures
por: Alter, Katharine E., et al.
Publicado: (2017) -
Chemodenervation for Oromandibular Dystonia Utilizing Botulinum Toxins
por: Ameer, Muhammad Atif, et al.
Publicado: (2021) -
Dual Treatment of Hemichorea–Hemiballismus Syndrome with Tetrabenazine and Chemodenervation
por: Umeh, Chizoba C., et al.
Publicado: (2012) -
Limb myorhythmia treated with chemodenervation: a case report
por: Saez-Calveras, Nil, et al.
Publicado: (2023) -
Binocular Visual Rehabilitation in Paralytic Strabismus by Botulinum A Toxin Chemodenervation
por: Kim, Myungjin, et al.
Publicado: (2022)